Read all three (3) articles (1. Drugs and the Media, 2. Public Enemy Number One, and 3. Miracle Drug, Poison, or Placebo: Patients’ Experiences with Antidepressant Medications as Described in Postings on an Online Message). As part of your discussion, answer the following five (5) questions:
Read all three (3) articles (1. Drugs and the Media, 2. Public Enemy Number One, and 3. Miracle Drug, Poison, or Placebo: Patients’ Experiences with Antidepressant Medications as Described in Postings on an Online Message). As part of your discussion, answer the following five (5) questions:
- According to the author of each article, what has been and is the role of the mass media?
- How is social media (YouTube, Twitter, Facebook, etc.) changing the landscape regarding “drug messages”?
- What new forms of or enhancements to social media can you envision over the next 5 years? How will be media’s role and hence its impact change in the future?
- How can the Pharmacists’ voices be heard in this new media environment?
- Given the rapidly moving marijuana legalization landscape, what biases now seem to be present in Nixon’s “War on Drugs”?
You are encouraged to look at additional current references from the literature (which you must properly cite) to support your points. Limit your initial post to no more than 500 words.
THESE ARE THE ARTICLES:
Drugs and the Media: An Introduction by Michael Montagne
Substance Use & Misuse, 46:849-851
Copyright 2011 Informa Healthcare USA, Inc.
ISSN: 1082-6084 print / 1532-2491 online
DOI: 10.3109/10826084.2011.57060
Public Enemy Number One: The US Advertising Council’s First Drug Abuse Prevention Campaign by Molly Niesen
Substance Use & Misuse, 46:872-881
Copyright 2011 Informa Healthcare USA, Inc.
ISSN: 1082-6084 print / 1532-2491 online
DOI: 10.3109/10826084.2011.570617
Miracle Drug, Poison, or Placebo: Patients’ Experiences with Antidepressant Medications as Described in Postings on an Online Message Board by Michael Montagne
Substance Use & Misuse, 46: pp. 922–930, (2011)
Copyright 2011 Informa Healthcare USA, Inc.
ISSN: 1082-6084 print / 1532-2491 online